These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37907036)

  • 21. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy.
    Tison F; Yekhlef F; Balestre E; Chrysostome V; Quinn N; Wenning GK; Poewe W
    Mov Disord; 2002 Nov; 17(6):1248-54. PubMed ID: 12465064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.
    Kawai Y; Suenaga M; Takeda A; Ito M; Watanabe H; Tanaka F; Kato K; Fukatsu H; Naganawa S; Kato T; Ito K; Sobue G
    Neurology; 2008 Apr; 70(16 Pt 2):1390-6. PubMed ID: 18413566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural history of multiple system atrophy: a prospective European cohort study.
    Wenning GK; Geser F; Krismer F; Seppi K; Duerr S; Boesch S; Köllensperger M; Goebel G; Pfeiffer KP; Barone P; Pellecchia MT; Quinn NP; Koukouni V; Fowler CJ; Schrag A; Mathias CJ; Giladi N; Gurevich T; Dupont E; Ostergaard K; Nilsson CF; Widner H; Oertel W; Eggert KM; Albanese A; del Sorbo F; Tolosa E; Cardozo A; Deuschl G; Hellriegel H; Klockgether T; Dodel R; Sampaio C; Coelho M; Djaldetti R; Melamed E; Gasser T; Kamm C; Meco G; Colosimo C; Rascol O; Meissner WG; Tison F; Poewe W;
    Lancet Neurol; 2013 Mar; 12(3):264-74. PubMed ID: 23391524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scale for Ocular Motor Disorders in Ataxia (SODA) in Patients with Multiple System Atrophy.
    Yoon H; Kwon H; Lee SU; Park E; Lee CN; Kim BJ; Kim JS; Park KW
    Cerebellum; 2024 Aug; 23(4):1369-1376. PubMed ID: 38117451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expanding concept of clinical conditions and symptoms in multiple system atrophy].
    Watanabe H; Riku Y; Nakamura T; Hara K; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
    Rinsho Shinkeigaku; 2016 Jul; 56(7):457-64. PubMed ID: 27356737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic diffusion tensor tractography in multiple system atrophy with predominant cerebellar ataxia and cortical cerebellar atrophy.
    Fukui Y; Hishikawa N; Sato K; Nakano Y; Morihara R; Ohta Y; Yamashita T; Abe K
    J Neurol; 2016 Jan; 263(1):61-7. PubMed ID: 26477028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease.
    Takei A; Honma S; Kawashima A; Yabe I; Fukazawa T; Hamada K; Hamada T; Tashiro K
    Psychiatry Clin Neurosci; 2002 Apr; 56(2):181-5. PubMed ID: 11952922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ; Hermann KL; Schmahmann JD
    Cerebellum; 2016 Dec; 15(6):663-679. PubMed ID: 26467153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-sectional study on drug use in multiple system atrophy.
    Rey MV; Perez-Lloret S; Pavy-Le Traon A; Meissner WG; Tison F; Rascol O
    CNS Drugs; 2014 May; 28(5):483-90. PubMed ID: 24683045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autonomic Disorder in Multiple System Atrophy].
    Sakakibara R
    Brain Nerve; 2022 Mar; 74(3):249-255. PubMed ID: 35260523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible multiple system atrophy with predominant parkinsonism in a patient with chronic schizophrenia: a case report.
    Komatsu H; Kato M; Kinpara T; Ono T; Kakuto Y
    BMC Psychiatry; 2018 May; 18(1):141. PubMed ID: 29783976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?
    Ferini-Strambi L; Marelli S; Combi R
    Curr Neurol Neurosci Rep; 2016 Dec; 16(12):105. PubMed ID: 27844341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].
    Yan XM; Li PJ; Li W; Wang XM; Yu S
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2933-2939. PubMed ID: 37752052
    [No Abstract]   [Full Text] [Related]  

  • 37. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.
    Iodice V; Lipp A; Ahlskog JE; Sandroni P; Fealey RD; Parisi JE; Matsumoto JY; Benarroch EE; Kimpinski K; Singer W; Gehrking TL; Gehrking JA; Sletten DM; Schmeichel AM; Bower JH; Gilman S; Figueroa J; Low PA
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):453-9. PubMed ID: 22228725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of tandospirone in the treatment of patients with anxiety disorder].
    Tao M; Han YJ; Gao JF; Tang WX; Zhu XZ; Tao DH; Zhang P; Zou Y; Chen H; Tao SF
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(13):920-3. PubMed ID: 22781535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatigue in Patients With Multiple System Atrophy: A Prospective Cohort Study.
    Zhang L; Cao B; Hou Y; Gu X; Wei QQ; Ou R; Zhao B; Song W; Shang H
    Neurology; 2022 Jan; 98(1):e73-e82. PubMed ID: 34663646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.